EP3853317A4 - Larmes artificielles, lentilles de contact et compositions de véhicule pour médicament et leurs procédés d'utilisation - Google Patents

Larmes artificielles, lentilles de contact et compositions de véhicule pour médicament et leurs procédés d'utilisation Download PDF

Info

Publication number
EP3853317A4
EP3853317A4 EP19863887.6A EP19863887A EP3853317A4 EP 3853317 A4 EP3853317 A4 EP 3853317A4 EP 19863887 A EP19863887 A EP 19863887A EP 3853317 A4 EP3853317 A4 EP 3853317A4
Authority
EP
European Patent Office
Prior art keywords
methods
contact lens
artificial tears
carrier compositions
medicinal carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19863887.6A
Other languages
German (de)
English (en)
Other versions
EP3853317A2 (fr
Inventor
Gerald Horn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ps Therapy Inc
Original Assignee
Ps Therapy Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/137,738 external-priority patent/US20190021990A1/en
Priority claimed from US16/372,596 external-priority patent/US20190225917A1/en
Priority claimed from US16/372,582 external-priority patent/US20190224136A1/en
Priority claimed from US16/372,625 external-priority patent/US11583496B2/en
Priority claimed from US16/412,943 external-priority patent/US20190262290A1/en
Application filed by Ps Therapy Ltd filed Critical Ps Therapy Ltd
Publication of EP3853317A2 publication Critical patent/EP3853317A2/fr
Publication of EP3853317A4 publication Critical patent/EP3853317A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP19863887.6A 2018-09-21 2019-09-19 Larmes artificielles, lentilles de contact et compositions de véhicule pour médicament et leurs procédés d'utilisation Withdrawn EP3853317A4 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US16/137,738 US20190021990A1 (en) 2016-10-12 2018-09-21 Artificial tear compositions and methods of use thereof
US16/372,596 US20190225917A1 (en) 2016-10-12 2019-04-02 Contact lens compositions and methods of use thereof
US16/372,582 US20190224136A1 (en) 2016-10-12 2019-04-02 Artificial tear compositions and methods of use thereof
US16/372,625 US11583496B2 (en) 2016-10-12 2019-04-02 Drug vehicle compositions and methods of use thereof
US16/412,943 US20190262290A1 (en) 2016-10-12 2019-05-15 Drug vehicle compositions and methods of use thereof
PCT/US2019/051825 WO2020061249A2 (fr) 2018-09-21 2019-09-19 Larmes artificielles, lentilles de contact et compositions de véhicule pour médicament et leurs procédés d'utilisation

Publications (2)

Publication Number Publication Date
EP3853317A2 EP3853317A2 (fr) 2021-07-28
EP3853317A4 true EP3853317A4 (fr) 2022-06-22

Family

ID=69887791

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19863887.6A Withdrawn EP3853317A4 (fr) 2018-09-21 2019-09-19 Larmes artificielles, lentilles de contact et compositions de véhicule pour médicament et leurs procédés d'utilisation

Country Status (6)

Country Link
EP (1) EP3853317A4 (fr)
JP (1) JP2022511335A (fr)
CN (1) CN113227304A (fr)
BR (1) BR112021005097A2 (fr)
CA (1) CA3112278A1 (fr)
WO (1) WO2020061249A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102365008B1 (ko) * 2020-06-23 2022-02-23 주식회사태준제약 디쿠아포솔을 포함하는 점안 조성물
WO2022189552A1 (fr) * 2021-03-10 2022-09-15 Bausch + Lomb Ireland Limited Solution de traitement de lentilles de contact sans conservateur
US12397518B2 (en) * 2021-04-29 2025-08-26 Coopervision International Limited WS12-releasing contact lens
CN115671256B (zh) * 2021-07-30 2024-04-09 四川大学华西医院 环孢素a与地夸磷索钠联合使用在制备治疗干眼症的药物中的用途
JP7664495B2 (ja) * 2022-10-31 2025-04-17 クーパーヴィジョン インターナショナル リミテッド Ｗｓ１２－放出コンタクトレンズ
CN117338787A (zh) * 2023-11-24 2024-01-05 南京恒道医药科技股份有限公司 一种眼用药物组合物及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140377210A1 (en) * 2013-06-21 2014-12-25 Gnt, Llc Artificial tear compositions
US20180098937A1 (en) * 2016-10-12 2018-04-12 Ps Therapies Ltd Artificial tear, contact lens and drug vehicle compositions and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1321144T3 (da) * 2000-09-13 2011-03-07 Santen Pharmaceutical Co Ltd Øjendråber
US20100239518A1 (en) * 2007-09-14 2010-09-23 Yasuko Matsumura Ophthalmic composition
AU2010339993A1 (en) * 2009-12-15 2012-07-26 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
US8597629B1 (en) * 2013-06-21 2013-12-03 Premium Ocular Solutions LLC. Artificial tear compositions comprising a combination of nonionic surfactants
EP3470059B1 (fr) * 2015-01-26 2020-04-01 Bausch & Lomb Incorporated Composition de suspension ophtalmique
JP7324566B2 (ja) * 2015-05-28 2023-08-10 ロート製薬株式会社 水性眼科組成物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140377210A1 (en) * 2013-06-21 2014-12-25 Gnt, Llc Artificial tear compositions
US20180098937A1 (en) * 2016-10-12 2018-04-12 Ps Therapies Ltd Artificial tear, contact lens and drug vehicle compositions and methods of use thereof

Also Published As

Publication number Publication date
CA3112278A1 (fr) 2020-03-26
EP3853317A2 (fr) 2021-07-28
JP2022511335A (ja) 2022-01-31
CN113227304A (zh) 2021-08-06
WO2020061249A3 (fr) 2020-07-23
WO2020061249A2 (fr) 2020-03-26
BR112021005097A2 (pt) 2021-06-08

Similar Documents

Publication Publication Date Title
EP3525885A4 (fr) Larmes artificielles, lentilles de contact et compositions de véhicule pour médicament et leurs procédés d'utilisation
EP3853317A4 (fr) Larmes artificielles, lentilles de contact et compositions de véhicule pour médicament et leurs procédés d'utilisation
EP3850088A4 (fr) Compositions et procédés d'amélioration de l'édition de base
EP4068387A4 (fr) Dispositif à semi-conducteur, son procédé de fabrication et son utilisation
EP3661966A4 (fr) Anticorps anti-cd39, compositions comprenant des anticorps anti-cd39 et méthodes d'utilisation d'anticorps anti-cd39
EP3730997A4 (fr) Procédé de fabrication de verre de lunettes et verre de lunettes
EP3576208A4 (fr) Batterie totalement solide et son procédé de production
EP3594312A4 (fr) Composition, procédé pour sa production et utilisation associée
EP3927020A4 (fr) Procédé de transfert de cellule, et dispositifs
EP3691677A4 (fr) Compositions de conjugués saccharide-polypeptide et leurs procédés d'utilisation
EP3581618A4 (fr) Composition de caoutchouc, et procédé de fabrication de celle-ci
EP3969054A4 (fr) Compositions contenant des médicaments solubles dans l'huile et méthodes d'utilisation de ces compositions
EP4025159A4 (fr) Méthodes et dispositifs pour la pose de prothèses implantables
EP3781102C0 (fr) Dispositifs d'administration de médicament dans l'oreille interne et procédés d'utilisation
EP3589326A4 (fr) Composition de gel parodontal et procédé d'utilisation
EP3851573A4 (fr) Cuir artificiel et son procédé de fabrication
EP3865542A4 (fr) Composition de silicone à durcissement par ajout et procédé pour la fabriquer
EP3265096C0 (fr) Compositions ophtalmiques et leurs procédés d'utilisation
EP3801422C0 (fr) Article de culotte jetable et procédé de production d'articles de culotte jetable
EP3855536A4 (fr) Batterie de stockage au plomb et son procédé de production
EP3606570A4 (fr) Compositions médicamenteuses à base de collagène peptidique et dispositifs et procédés pour les produire et les utiliser
EP3770268A4 (fr) MÉTHODE DE PRODUCTION DE ß-NMN ET COMPOSITION EN CONTENANT
EP3768315A4 (fr) Compositions de variant fc et leurs procédés d'utilisation
EP3790559A4 (fr) Compositions photodynamiques et méthodes d'utilisation
EP3678701A4 (fr) Compositions protéiques thérapeutiques et procédés de préparation et d'utilisation de celles-ci

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210329

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220524

RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 12/12 20060101ALN20220518BHEP

Ipc: A61K 9/08 20060101ALI20220518BHEP

Ipc: C09K 3/00 20060101AFI20220518BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PS THERAPY, INC.

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230426

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250401